Similarly, a recent study of 1764 patients with advanced melanoma from a nationwide registry confirmed the prolonged mPFS and mOS in BRAF-mutant melanoma compared with NRAS-mutant and double wild-type melanoma [64]. This evidence concerns the gene NRAS and melanoma.